Intestinal invasion by Entamoeba histolytica

Subcellular Biochemistry

Volumn 47, Issue , 2008, Pages 221-232

  Solaymani Mohammadi, Shahram ^a   Petri, William A ^b  

^a University of Virginia Health System ^*

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTAMOEBA HISTOLYTICA;

LECTIN; VIRULENCE FACTOR;

AMEBIASIS; ANIMAL; ARTICLE; ENTAMOEBA HISTOLYTICA; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; LIFE CYCLE; PARASITOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HOST-PARASITE INTERACTIONS; HUMANS; INTESTINAL MUCOSA; LECTINS; LIFE CYCLE STAGES; VIRULENCE FACTORS;

EID: 46249132162     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78267-6_18     Document Type: Article

References (82)

1. World Health Organization: Amebiasis. WHO Weekly Epidemiological Records 1997; 72:97-100.
2. Lamont JT. Mucus: The front line of intestinal mucosal defense. Ann NY Acad Sci 1992; 664:190-201.
3. Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem 1999; 274(45):31751-31754.
4. Moncada DM, Kammanadiminti SJ, Chadee K. Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol 2003; 19(7):305-311.
5. Forstner JF, Oliver MG, Sylvester FA. Production, structure, and biologic relevance of gastrointes tinal mucins. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:71-88.
6. Deplancke B, Gaskins HR. Microbial modulation of innate defense: Goblet cells and the intestinal mucus layer. Am J Clinical Nutrition 2001; 73(6): 13IS-141.
7. Chadee K, Petri Jr WA, Innes DJ et al. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest 1987; 80(5): 1245-1254.
8. Chadee K, Meerovitch E. Entamoeba histolytica: Early progressive pathology in the cecum of the gerbil (Meriones unguiculatus). Am J Trop Med Hyg 1985; 34:283-291.
9. Belley A, Keller K, Gottke M et al. Intestinal mucins in colonization and host defense against pathogens. Am J Trop Med Hyg 1999; 60:10-15.
10. Ravdin JI. Immunobiology of human infection by Entamoeba histolytica. Pathol Immunopathol Res 1989; 8(3-4): 179-205.
11. Belley A, Keller K, Grove J et al. Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: An in vitro model for colonic disease. Gastroenterology 1996; 111(6):1484-1492.
12. Stenson WF, Zhang Z, Riehl T et al. Amebic infection in the human colon induces cyclooxygenase-2. Infect Immun 2001; 69(5):3382-8.
13. Huldt G, Davies P, Allison AC et al. Interactions between Entamoeba histolytica and complement. Nature 1979; 277(5693):214-216.
14. Meri S, Richaud G, Linder E. Complement activation by antigenic fractions of Entamoeba histolytica. Parasite Immunol 1985; 7(2): 153-164.
15. Calderon J, Schreiber RD. Activation of the alternative and classical complement pathways by Entamoeba histolytica. Infect Immun 1985; 50:560-565.
16. Munoz LE, Salazar OG. Complement activation in patients with amebic liver abscess. J Hepatol 1987; 5(l):30-36.
17. Reed SL, Keene WE, McKerrow JH et al. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica. J Immunol 1989; 143:189-195.
18. Walderich B, Weber A, Knobloch J. Sensitivity of Entamoeba histolytica and Entamoeba dispar patient isolates to human complement. Parasite Immunol 1997; 19(6):265-271.
19. Reed SL, Curd JG, Gigli I et al. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica. J Immunol 1986; 136(6):2265-2270.
20. Capin R, Capin NR, Carmona M et al. Effect of complement depletion on the induction of amebic liver abscess in the hamster. Arch Invest Med (Mex) 1980; 11(1 Suppl):173-180.
21. Braga LL, Ninomiya H, McCoy JJ et al. Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest 1992; 90(3):1131-1137.
22. Mann BJ. Structure and function of the Entamoeba histolytica Gal/GalNAc lectin. Int Rev Cytol 2002; 216:59-80.
23. Petri Jr WA, Chapman MD, Snodgrass T et al. Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem 1989; 264(5):3007-3012.
24. Cheng XJ, Hughes MA, Huston CD et al. Intermediate subunit of the Gal/GalNAc lectin of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs. Infect Immun 2001; 69(9):5892-8.
25. Stanley Jr SL, Huizenga H, Li E. Isolation and partial characterization of a surface glycoconjugate of Entamoeba histolytica. Mol Biochem Parasitol 1992; 50(1): 127-138.
26. Dodson JM, Lenkowski Jr PW, Eubanks AC et al. Infection and immunity mediated by the carbo hydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J Infect Dis 1999; 179(2):460-466.
27. McCoy JJ, Weaver AM, Petri Jr WA. Use of monoclonal anti-light subunit antibodies to study the structure and function of the Entamoeba histolytica Gal/GalNAc adherence lectin. Glycoconj J 1994; 11(5):432-436.
28. Ravdin JI, John JE, Johnston LI et al. Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa. Infect Immun 1985; 48(2):292-297.
29. Bracha R, Mirelman D. Adherence and ingestion of Escherichia coli serotype 055 by trophozoites of Entamoeba histolytica. Infect Immun 1983; 40(3):882-887.
30. Petri Jr WA, Haque R, Mann BJ. The bittersweet interface of parasite and host: Lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol 2002; 56:39-64.
31. Petri Jr WA, Joyce MP, Broman J et al. Recognition of the galactose-or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera. Infect Immun 1987; 55(10):2327-2331.
32. Saffer LD, Petri Jr WA. Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infect Immun 1991; 59(12):4681-4683.
33. Mann BJ, Lockhart LA. Molecular analysis of the Gal/GalNAc adhesin of Entamoeba histolytica. J Eukaryot Microbiol 1998; 45(2):13S-16S.
34. Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990; 8:279-302.
35. Lynch EC, Rosenberg IM, Gitler C. An ion-channel forming protein produced by Entamoeba histolytica. EMBO J 1982; 1(7):801-804.
36. Rosenberg I, Gitler C. Subcellular fractionation of amoebapore and plasma membrane components of Entamoeba histolytica using self-generating PercoU gradients. Mol Biochem Parasitol 1985; 14(2):231-248.
37. Leippe M, Tannich E, Nickel R et al. Primary and secondary structure of the pore-forming pep tide of pathogenic Entamoeba histolytica. EMBO J 1992; 11(10):3501-3506.
38. Leippe M, Andra J, Nickel R et al. Amoebapores, a family of membranolytic peptides from cyto plasmic granules of Entamoeba histolytica: Isolation, primary structure, and pore formation in bac terial cytoplasmic membranes. Mol Microbiol 1994; 14(5):895-904.
39. Loftus B, Anderson I, Davis R et al. The genome of the protest parasite Entamoeba histolytica. Nature 2005; 433(7028):865-868.
40. Leippe M. Amoebapores. Parasitol Today 1997; 13(5):178-183.
41. Leippe M, Andra J, Nickel R et al. Amoebapores, a family of membranolytic peptides from cyto plasmic granules of Entamoeba histolytica: Isolation, primary structure, and pore formation in bac terial cytoplasmic membranes. Mol Microbiol 1994; 14(5):895-904.
42. Leippe M, Bahr E, Tannich E et al. Comparison of pore-forming peptides from pathogenic and nonpathogenic Entamoeba histolytica. Mol Biochem Parasitol 1993; 59(1): 101-109.
43. Leippe M, Sievertsen HJ, Tannich E et al. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica. Parasitology 1995; 111 (P t 5):569-574.
44. Tannich E. Entamoeba histolytica and E. dispar: Comparison of molecules considered important for host tissue destruction. Trans R Soc Trop Med Hyg 1998; 92(6):593-596.
45. Berti PJ, Storer AC. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 1995; 246:273-283.
46. Sloane BF, Rozhin J, Hatfield JS et al. Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 1987; 55:209-224.
47. My AS, Matuschewski K. A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med 2005; 202(2):225-30
48. Scholze H, Schulte W. On the specificity of a cysteine proteinase from Entamoeba histolytica. Biomed Biochim Acta 1988; 47(2):115-123.
49. Luaces AL, Barrett AJ. Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem J 1988; 250(3):903-909.
50. Keene WE, Hidalgo ME, Orozco E et al. Entamoeba histolytica: Correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Exp Parasitol 1990; 71(2):199-206.
51. Reed SL, Keene WE, McKerrow JH. Thiol proteinase expression and pathogenicity of Entamoeba histolytica. J CUn Microbiol 1989; 27(12):2772-2777.
52. Jacobs T, Bruchhaus I, Dandekar T et al. Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica. Mol Microbiol 1998; 27:269-276.
53. Bruchhaus I, Jacobs T, Leippe M et al. Entamoeba histolytica and Entamoeba dispar: Differences in numbers and expression of cysteine proteinase genes. Mol Microbiol 1996; 22(2):255-263.
54. Willhoeft U, Hamann L, Tannich E. A DNA sequence corresponding to the gene encoding cys teine proteinase 5 in Entamoeba histolytica is present and positionally conserved but highly degen erated in Entamoeba dispar. Infect Immun 1999; 67:5925-5929.
55. Forney JR, Yang S, Healy MC. Protease activity associated with excystation of Cryptosporidium parvum oocysts. J Parasitology 1996; 82(6):889-892.
56. Keene WE, Petitt MG, Allen S et al. The major neutral proteinase of Entamoeba histolytica. J Exp Med 1986; 163(3):536-549.
57. Reed S, Bouvier J, Pollack AS et al. Cloning of a virulence factor of Entamoeba histolytica: Patho genic strains possess a unique cysteine proteinase gene. J Clin Invest 1993; 91(4): 1532-1540.
58. Li E, Yang WG, Zhang T et al. Interaction of laminin with Entamoeba histolytica cysteine pro teinases and its effect on amebic pathogenesis. Infect Immun 1995; 63(10):4150-4153.
59. Que X, Reed SL. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000; 13(2):196-206.
60. Moncada D, Keller K, Ankri S et al. Antisense inhibition of Entamoeba histolytica cysteine pro teases inhibits colonic mucus degradation. Gastroenterology 2006; 130(3):721-30.
61. Meza I. Extracellular matrix-induced signaling in Entamoeba histolytica: Its role in invasiveness. Parasitol Today 2000; 16(l):23-28.
62. Carbajal ME, Manning-Cela R, Pina A et al. Fibronectin-induced intracellular calcium rise in En tamoeba histolytica trophozoites: Effect on adhesion and the actin cytoskeleton. Exp Parasitol 1996; 82 (l): 11 - 2 0.
63. Santiago A, Carbajal ME, Benitez-King G et al. Entamoeba histolytica: PKC transduction pathway activation in the trophozoite-fibronectin interaction. Exp Parasitol 1994; 79(3):436-444.
64. Munoz ML, Lamoyi E, Leon G et al. Antigens in electron-dense granules from Entamoeba histolytica as possible markers for pathogenicity. J CHn Microbiol 1990; 28(11):2418-2424.
65. Perez E, Munoz ML, Ortega A. Entamoeba histolytica: Involvement of ppl25FAK in collagen-induced signal transduction. Exp Parasitol 1996; 82(2): 164-170.
66. de Lourdes Munoz M, Das P, Tovar R. Entamoeba histolytica trophozoites activated by collagen type I and Ca2+ have a structured cytoskeleton during collagenase secretion. Cell Motil Cytoskel eton 2001; 50(l):45-54. G7.
67. Debnath A, Akbar MA, Mazumder A et al. Entamoeba histolytica: Characterization of human collagen type I and Ca2+ activated differentially expressed genes. Exp Parasitol 2005; 110(3):214-219.
68. Ghosh SK, Samuelson J. Involvement of p21racA, phosphoinositide 3-kinase, and vacuolar ATPase in phagocytosis of bacteria and erythrocytes by Entamoeba histolytica: Suggestive evidence for co incidental evolution of amebic invasiveness. Infect Immun 1997; 65(10):4243-4249.
69. Aguilar-Rojas A, Almaraz-Barrera Mde J, Krzeminski M et al. Entamoeba histolytica: Inhibition of cellular functions by overexpression of EhGEF 1, a novel Rho/Rac guaninenucleotide exchange fac tor. Exp Parasitol 2005; 109(3):150-162.
70. Lohia A, Samuelson J. Molecular cloning of a rho family gene of Entamoeba histolytica. Mol Biochem Parasitol 1993; 58(1):177-180.
71. Beck DL, Boettner DR, Dragulev B et al. Identification and gene expression analysis of a large family of transmembrane kinases related to the Gal/GalNAc lectin in Entamoeba histolytica. Eukaryot Cell 2005; 4(4):722-32.
72. Kelsall BL, Ravdin JI. Degradation of human IgA by Entamoeba histolytica. J Infect Dis 1993; 168(5):1319-1322.
73. Espinosa-Cantellano M, Martinez-Palomo A. Entamoeba histolytica: Mechanism of surface recep tor capping. Exp Parasitol 1994; 79(3):424-435.
74. Arhets P, Gounon P, Sansonetti P et al. Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica. Infect Immun 1995; 63(ll):4358-4367.
75. Zambrano-Villa S, Rosales-Borjas D, Carrero JC et al. How protozoan parasites evade the immune response. Trends Parasitol 2002; (6):272-278.
76. Ortiz-Ortiz L, Zamacona G, Sepulveda B et al. Cell-mediated immunity in patients with amebic abscess of the liver. Clin Immunol Immunopathol 1975; 4(1): 127-134.
77. Ghosh PK, Castellanos-Barba C, Ortiz-Ortiz L. Intestinal amebiasis: Cyclic suppression of the immune response. Parasitol Res 1995; 81(6):475-480.
78. Rico G, Diaz-Guerra O, Kretschmer RR. Cyclic nucleotide changes induced in human leukocytes by a product of axenically grown Entamoeba histolytica that inhibits human monocyte locomo tion. Parasitol Res 1995; 81(2): 158-162.
79. Wang W, Chadee K. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex la molecule and I-A beta mRNA expression by a prostaglan din E2-dependent mechanism. Infect Immun 1995; 63(3): 1089-1094.
80. Wang W, Keller K, Chadee K. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect Immun 1992; 60(8):3169-3174.
81. Calderon J, Tovar R. Loss of susceptibility to complement lysis in Entamoeba histolytica HMl by treatment with human serum. Immunology 1986; 58(3):467-471.
82. Houpt ER, Glembocki DJ, Obrig TG et al. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J Immunol 2002; 169(8):4496-503.